SPRYCEL (Dasatinib)- 50mg

SPRYCEL (Dasatinib)- 50mg

SPRYCEL (Dasatinib) belongs to the signal transduction inhibitor category of targeted therapies.  It particularly interferes with multiple protein-tyrosine kinases.

SPRYCEL is used for;

  • Treatment of chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy.
  • Treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) with resistance or intolerance to prior therapy.
Enquiry Now
Categories: ,

Additional information

Trade Name

Sprycel
Generic Name

Dasatinib
Manufacturer

Bristol-Myers Squibb
Drug Type

Oncology
Indication

Blood cancer / Leukamia
Doasage Form

Tablet
Packaging

60 Tablets / Bottle

Related products